drugset
drugset / Trial / NCT00944372

Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors

NCT00944372 ↗

Phase 4 Terminated 150 enrolled Mallinckrodt
Non-randomizedFactorialOpen-labelDiagnostic

Summary

The objective of this study was to evaluate the effect of age (geriatric) and renal function on the safety, efficacy and pharmacokinetics of OctreoScan at the recommended clinical dose in this patient population.

Timeline

Start
2003-07
Primary completion
2005-08
Completion
2005-08

Outcome

Outcome not reported

Stopped (Enrollment): “Enrollment was difficult”

Drugs

EvaluationDrugModalityDoseRoute
Subject INDIUM PENTETREOTIDE Protein / enzyme biologic 222 mbq Intravenous

Indications

cancer